Implementing US-style anti-fraud laws in the Australian pharmaceutical and health care industries
This article critically analyses the prospects for introducing United States anti-fraud (or anti-false claims) laws in the Australian health care setting. Australian governments spend billions of dollars each year on medicines and health care. A recent report estimates that the money lost to corporate fraud in Australia is growing at an annual rate of 7%, but that only a third of the losses are currently being detected. In the US, qui tam provisions - the component of anti-fraud or anti-false...[Show more]
|Collections||ANU Research Publications|
|Source:||Medical Journal of Australia|
|01_Faunce_Implementing_US-style_2011.pdf||233.93 kB||Adobe PDF|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.